Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China

Huang, J; Mo, HN; Zhang, WL; Chen, XL; Qu, D; Wang, X; Wu, DW; Wang, XY; Lan, B; Yang, BB; Wang, P; Zhang, B; Yang, Q; Jiao, YC; Xu, BH

Huang, J; Xu, BH (reprint author), Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China.; Huang, J; Jiao, YC; Xu, BH (reprint author), Peking Union Med Coll, 17 Panjiay

CANCER, 2019; 125 (5): 742

Abstract

Background The clinical response to anti-programmed cell death 1 (PD-1) antibodies in patients with advanced gastric and gastroesophageal junction (GE......

Full Text Link